1395 Piccard Drive
Rockville, MD 20850
This author has not yet filled in any details.
So far Richard Clayton has created 0 blog entries.
Therabron Therapeutics Receives Orphan Drug Designation in the European Union for CG367.
Therabron Therapeutics to Present at Stifel 2016 Healthcare Conference
Therabron Therapeutics Receives from FDA Rare Pediatric Disease Designation for Lead Phase 2 Program in Preterm Infants
Therabron Therapeutics to Present at Upcoming Industry and Investor Conferences
Therabron Therapeutics Completes Enrollment of Phase 2 Clinical Trial for Lead Product Candidate CG100 for the Prevention of Chronic Lung Disease in Preterm Infants